# Comparison of the Safety of Q8003 Versus Morphine Equivalent Doses of Its Components (Oxycodone and Morphine) in Bunionectomy Patients

> **NCT01280331** · PHASE3 · COMPLETED · sponsor: **QRxPharma Inc.** · enrollment: 375 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Q8003 (morphine sulfate and oxycodone hydrochloride)
- **DRUG:** Morphine sulfate
- **DRUG:** Oxycodone HCl

## Key facts

- **NCT ID:** NCT01280331
- **Lead sponsor:** QRxPharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 375 (ACTUAL)
- **Last updated:** 2012-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01280331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01280331, "Comparison of the Safety of Q8003 Versus Morphine Equivalent Doses of Its Components (Oxycodone and Morphine) in Bunionectomy Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01280331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*